The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia..
22. maí 2020Karen E. Heath, Vilmundur Gudnason, Steve E. Humphries, Mary Seed. Atherosclerosis 1999;143: 41-54.
